Literature DB >> 27365393

Phosphorylation of Leukotriene C4 Synthase at Serine 36 Impairs Catalytic Activity.

Shabbir Ahmad1, A Jimmy Ytterberg2, Madhuranayaki Thulasingam1, Fredrik Tholander3, Tomas Bergman4, Roman Zubarev4, Anders Wetterholm1, Agnes Rinaldo-Matthis1, Jesper Z Haeggström5.   

Abstract

Leukotriene C4 synthase (LTC4S) catalyzes the formation of the proinflammatory lipid mediator leukotriene C4 (LTC4). LTC4 is the parent molecule of the cysteinyl leukotrienes, which are recognized for their pathogenic role in asthma and allergic diseases. Cellular LTC4S activity is suppressed by PKC-mediated phosphorylation, and recently a downstream p70S6k was shown to play an important role in this process. Here, we identified Ser(36) as the major p70S6k phosphorylation site, along with a low frequency site at Thr(40), using an in vitro phosphorylation assay combined with mass spectrometry. The functional consequences of p70S6k phosphorylation were tested with the phosphomimetic mutant S36E, which displayed only about 20% (20 μmol/min/mg) of the activity of WT enzyme (95 μmol/min/mg), whereas the enzyme activity of T40E was not significantly affected. The enzyme activity of S36E increased linearly with increasing LTA4 concentrations during the steady-state kinetics analysis, indicating poor lipid substrate binding. The Ser(36) is located in a loop region close to the entrance of the proposed substrate binding pocket. Comparative molecular dynamics indicated that Ser(36) upon phosphorylation will pull the first luminal loop of LTC4S toward the neighboring subunit of the functional homotrimer, thereby forming hydrogen bonds with Arg(104) in the adjacent subunit. Because Arg(104) is a key catalytic residue responsible for stabilization of the glutathione thiolate anion, this phosphorylation-induced interaction leads to a reduction of the catalytic activity. In addition, the positional shift of the loop and its interaction with the neighboring subunit affect active site access. Thus, our mutational and kinetic data, together with molecular simulations, suggest that phosphorylation of Ser(36) inhibits the catalytic function of LTC4S by interference with the catalytic machinery.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  MAPEG; cysteinyl leukotrienes; drug development; eicosanoid specific enzyme; leukotriene; leukotriene C4 synthase; membrane enzyme; p70S6k; phosphoproteomics; phosphoregulation

Mesh:

Substances:

Year:  2016        PMID: 27365393      PMCID: PMC5000086          DOI: 10.1074/jbc.M116.735647

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  The origins of protein phosphorylation.

Authors:  Philip Cohen
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

3.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

4.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

5.  Making optimal use of empirical energy functions: force-field parameterization in crystal space.

Authors:  Elmar Krieger; Tom Darden; Sander B Nabuurs; Alexei Finkelstein; Gert Vriend
Journal:  Proteins       Date:  2004-12-01

Review 6.  Treatment of asthma with drugs modifying the leukotriene pathway.

Authors:  J M Drazen; E Israel; P M O'Byrne
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

7.  Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase.

Authors:  R A Lepley; D T Muskardin; F A Fitzpatrick
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

8.  Tandem Benzophenone Amino Pyridines, Potent and Selective Inhibitors of Human Leukotriene C4 Synthase.

Authors:  Thea K Kleinschmidt; Martin Haraldsson; Devaraj Basavarajappa; Erik Lundeberg; Madhuranayaki Thulasingam; Maria Ekoff; Alexander Fauland; Christoph Lehmann; Astrid S Kahnt; Lennart Lindbom; Jesper Z Haeggström
Journal:  J Pharmacol Exp Ther       Date:  2015-08-17       Impact factor: 4.030

Review 9.  Leukotriene C(4) synthase.

Authors:  Bing K Lam
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003 Aug-Sep       Impact factor: 4.006

10.  Activation of protein kinase C down-regulates leukotriene C4 synthase activity and attenuates cysteinyl leukotriene production in an eosinophilic substrain of HL-60 cells.

Authors:  A Ali; A W Ford-Hutchinson; D W Nicholson
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

View more
  2 in total

Review 1.  Leukotriene biosynthetic enzymes as therapeutic targets.

Authors:  Jesper Z Haeggström
Journal:  J Clin Invest       Date:  2018-07-02       Impact factor: 14.808

2.  Leukotriene B₄ Metabolism and p70S6 Kinase 1 Inhibitors: PF-4708671 but Not LY2584702 Inhibits CYP4F3A and the ω-Oxidation of Leukotriene B₄ In Vitro and In Cellulo.

Authors:  Anne-Sophie Archambault; Caroline Turcotte; Cyril Martin; Julie S Lefebvre; Véronique Provost; Michel Laviolette; Nicolas Flamand
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.